Skip to content

Penile cancer specialist centres NSW

Criteria for a specialist penile cancer centre

The National Institute for Clinical Excellence (NICE) guidelines state people diagnosed with penile cancer should be managed in centralised specialty centres to improve quality of care and outcomes.(1, 2) Each specialty centre should have a specialist penile cancer multidisciplinary team composed of experts in penile cancer.(1)

For facilities to be considered specialist centres they should:

  1. Access to an onsite urological multidisciplinary cancer care team (MDT).(1, 3)
  2. Membership includes a Urologist with a special interest in penile cancer who is willing to perform inguinal lymph node excision.(3)
  3. The multidisciplinary team has capability to coordinate a penile cancer multidisciplinary team teleconference between promoted NSW centres.(1, 3)
  4. The facility averaged one penile cancer amputation per year over the four year period reported. (2, 4)
  5. The facility averaged one penile cancer lymph node excision per year over the four year period reported. (2, 3)
  6. The facility has the ability to perform dynamic sentinel node biopsy and access to positron emission tomography (PET) in order to optimise outcomes following penile cancer surgery.(4, 5)

*The criteria are based on international studies and local clinical advisory group endorsement.

Availability of a multidisciplinary cancer care team

People diagnosed with penile cancer may have one or more types of treatments, including laser therapy, surgery, chemotherapy and radiotherapy.

The involvement of a multidisciplinary cancer care team is required.(6) This team brings together health care professionals from different specialties to discuss a patient’s cancer diagnosis and staging, and their treatment options. It also enhances communication and care co-ordination between the specialists involved in a patient’s care.

International studies show that patients overseen by a multidisciplinary cancer care team experience better outcomes after cancer treatment.(7-9)

Actions for Health Professionals

Actions for Health Professionals

Patient referral

Patients with a suspected or confirmed penile cancer should be referred to a specialist who is a member of a multidisciplinary cancer care team, and practices at one of the specialist centres listed below.

Even if surgery does not seem likely at the time of referral, involvement of an appropriate a multidisciplinary team (MDT) early in the cancer journey is recommended to ensure optimal assessment, care, and outcomes.

The Canrefer website allows you to find cancer specialists who are MDT members, and has information about cancer services, optimal care pathways, and patient resources.

Smoking cessation support

Evidence suggests that tobacco cessation following cancer diagnosis improves survival. It also reduces treatment-related complications.[13–14] Health professionals should discuss tobacco use with all patients and provide appropriate cessation support.

List of public specialist centres for penile cancer surgery

Local health District

Hospital

Illawarra Shoalhaven

Wollongong Hospital

Sydney

Royal Prince Alfred Hospital

References

  1. Eastwood A FA, Kleijnen J, Lister-Sharp D, Velindre M. Guidance on Cancer Services Improving Outcomes in Urological Cancers The Manual. National Institute for Clinical Excellence. 2002.
  2. England N. Penile cancer service specification, schedule 2 - the Sevices.
  3. O.W. Hakenberg (Chair) EC, S. Minhas,A. Necchi, C. Protzel, N. Watkin. Penile Cancer. EAU Guidelines. 2016.
  4. Penile Cancer. Nationa Comprehensive Cancer Network (NCCN). 2020.
  5. Patel MI, Yuminaga Y, Bang A, Lawrentschuk N, Skyring T, Smith DP. Volume-outcome relationship in penile cancer treatment: a population based patterns of care and outcomes study from Australia. BJU International. 2016;118:35-42.
  6. Australia C. All about multidisciplinary care 2014 [Available from: https://canceraustralia.gov.au/clinical-best-practice/multidisciplinary-care/all-about-multidisciplinary-care.
  7. Patel MI, Bang A, Gillatt D, Smith DP. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study. BJU Int. 2015;116 Suppl 3:18-25.
  8. Sooriakumaran P, Dick JA, Thompson AC, Morley R. The central urology multidisciplinary team - is it time to change the referral criteria? An audit of practice in a district general hospital in London. Annals of the Royal College of Surgeons of England. 2009;91(8):700-2.
  9. Abdulrahman GO, Jr. The effect of multidisciplinary team care on cancer management. The Pan African medical journal. 2011;9:20.
  10.  Hounsome L, Verne J, Persad R, Bahl A, Gillatt D, Oxley J, et al. An audit of urological MDT decision making in the South West of England. Journal of Clinical Urology. 2018;11(4):254-7.
  11. Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. The Lancet Oncology. 2014;15(12):e568-80.